Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9597380 Terminally modified RNA

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 2, 2013
Date of Patent
March 21, 2017
Patent Application Number
14043927
Patent Citations Received
‌
US Patent 12133899 Coronavirus vaccine
0
‌
US Patent 12090235 Preparation of lipid nanoparticles and methods of administration thereof
0
‌
US Patent 12103955 Polynucleotides encoding relaxin
0
‌
US Patent 12128113 Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome
0
‌
US Patent 11708396 Signal-sensor polynucleotides for the alteration of cellular phenotypes
0
‌
US Patent 11708572 Acoustic cell separation techniques and processes
0
‌
US Patent 11744801 Methods of making lipid nanoparticles
‌
US Patent 11752206 Herpes simplex virus vaccine
‌
US Patent 11767548 RNA polymerase variants
‌
US Patent 11779659 RNA constructs and uses thereof
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9597380
Patent Primary Examiner
‌
Christopher M Babic

Find more entities like US Patent 9597380 Terminally modified RNA

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.